Stimdia Medical announced recently that it completed the initial closing of a $16 million tranche of its Series B financing round. Solas Bioventures led the financing round, while new strategic partners and existing investors Draper Triangle Ventures also contributed funding. Minneapolis-based Stimdia designed its pdSTIM system to offer a tool for addressing high-risk patients, including […]
Stimdia Medical
FDA grants breakthrough nod for system to wean people from mechanical ventilation
Stimdia Medical announced today that it received FDA breakthrough device designation for its pdSTIM system. Minneapolis-based Stimdia’s pdSTIM system is designed to offer a tool in addressing high-risk patients, including those with COVID-19, by providing a minimally invasive neurostimulation solution to awaken and recondition the diaphragm, according to a news release. The platform facilitates the […]